Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
October 2022 Vol. 10 No. 5
Clostridioides difficile in pregnancy
Clostridioides difficile (C. difficile), commonly known as C. diff, is a bacteria associated with severe diarrhea and inflammation of the…
Depressive symptoms in perimenopause
Depressive symptoms are common in perimenopause. Women who may be more at risk include those with a family history or…
Destigmatizing abortion in primary care settings
Many nurse practitioners (NPs) in primary care settings are feeling lost or helpless since the Supreme Court decision in the…
Editor-in-chief’s message, October 2022
Dear Colleagues, Beth Kelsey, Editor in Chief, Women’s Healthcare I love words. That is a good thing for an editor.…
Improving depression and anxiety screening in an infertility practice through implementation of an evidence-based screening tool and process
Infertility affects approximately 11% of women and 9% of men in the United States who are of reproductive age.1 Patients…
Perinatal care considerations for women who have experienced type 3 female genital cutting/infibulation
This article provides information and care guidelines for healthcare providers who encounter pregnant women who have experienced type 3 female…
Polycystic ovary syndrome (PCOS): Diagnosis and management
Faculty: Terrie H. Platt, DNP, RN, WHNP-BC, NCMP, is Assistant Professor at the University of South Alabama College of Nursing…
Position Statement: Access to Safe Abortion Care
The National Association of Nurse Practitioners in Women’s Health (NPWH), along with numerous other national health professional organizations, affirms that…